News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endologix Inc. Comments on Alleged Patent Infringement



1/2/2013 9:09:50 AM

IRVINE, Calif., Dec. 31, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has become aware that Lifeport Sciences, LLC, which is affiliated with Acacia Research Corporation, has filed a lawsuit against Endologix in the United States District Court in Delaware alleging that Endologix's AFX Endovascular AAA System and IntuiTrak Powerlink System infringe five of Lifeport's U.S. patents. The five patents are scheduled to expire on various dates between 2013 and 2015.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES